Open-mkt buys · 90d
$28.8K
2 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$28.8K
Insiders on file
17
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Capers Julien E. | See Remarks | 1 | $0 | $0 | 2026-10-19 |
| Jones Mitchell Lawrence | See Remarks | 37 | $0 | $109.8K | 2026-10-06 |
| Finley John David | Chief Financial Officer | 114 | $101.5K | $310.7K | 2026-10-06 |
| Williams Donald Allen | Director | 23 | $68.3K | $0 | 2026-10-02 |
| Baltera Robert Jr. | Director | 7 | $250.1K | $0 | 2026-07-09 |
| Zwick Jordan Michael | Director | 1 | $0 | $0 | 2026-06-10 |
| Chuang Emil | Director | 7 | $0 | $0 | 2026-06-10 |
| Wei Binxian | Director | 14 | $0 | $0 | 2026-06-10 |
| Fischbein Margery B. | Director | 1 | $0 | $0 | 2024-07-11 |
| Neal James R | Director | 19 | $0 | $0 | 2024-02-09 |
| Diaz Stephanie | Director | 15 | $0 | $0 | 2024-02-08 |
| Trenschel Robert J. | Director | 26 | $42.3K | $192 | 2024-02-08 |
| Csimma Cristina | Director | 13 | $0 | $0 | 2024-02-08 |
| GRAY MARY ANN | Director | 5 | $0 | $0 | 2023-11-21 |
| McRae Robert Curtis | Chief Operating Officer | 3 | $0 | $0 | 2023-04-03 |
| Hallam Thomas | Chief Executive Officer | 20 | $36.7K | $0 | 2022-08-16 |
| Dawson Michael John | Chief Medical Officer | 8 | $17.1K | $0 | 2022-03-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Capers Julien E. | See Remarks | A Award | 2026-10-19 | 2026-10-21 | 787,300 | — | — | 787,300 | SEC↗ |
| Jones Mitchell Lawrence | See Remarks | M Exercise deriv | 2026-10-06 | 2026-10-07 | 65,584 | — | $0 | 590,249 | SEC↗ |
| Jones Mitchell Lawrence | See Remarks | M Exercise deriv | 2026-10-06 | 2026-10-07 | 2,555,266 | — | $0 | 5,110,534 | SEC↗ |
| Jones Mitchell Lawrence | See Remarks | F Tax w/h | 2026-10-06 | 2026-10-07 | 1,031,102 | $1.49 | $1.54M | 1,683,757 | SEC↗ |
| Jones Mitchell Lawrence | See Remarks | M Exercise | 2026-10-06 | 2026-10-07 | 2,620,850 | — | — | 2,714,859 | SEC↗ |
| Finley John David | CEO CFO, Director | M Exercise deriv | 2026-10-06 | 2026-10-07 | 167,584 | — | $0 | 1,508,249 | SEC↗ |
| Finley John David | CEO CFO, Director | M Exercise deriv | 2026-10-06 | 2026-10-07 | 3,059,800 | — | $0 | 6,119,600 | SEC↗ |
| Finley John David | CEO CFO, Director | F Tax w/h | 2026-10-06 | 2026-10-07 | 1,411,982 | $1.49 | $2.10M | 1,944,690 | SEC↗ |
| Finley John David | CEO CFO, Director | M Exercise | 2026-10-06 | 2026-10-07 | 3,227,384 | — | — | 3,356,672 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2026-10-02 | 2026-10-05 | 10,000 | $1.46 | $14.6K | 1,590,294 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2026-10-01 | 2026-10-05 | 10,000 | $1.42 | $14.2K | 1,580,294 | SEC↗ |
| Finley John David | CEO, CFO | G Gift | 2026-08-19 | 2026-08-21 | 88,400 | — | $0 | 129,288 | SEC↗ |
| Finley John David | CEO, CFO | G Gift | 2026-08-19 | 2026-08-21 | 88,400 | — | $0 | 88,451 | SEC↗ |
| Finley John David | CEO, CFO, Director | G Gift | 2026-08-19 | 2026-08-21 | 88,400 | — | $0 | 88,451 | SEC↗ |
| Finley John David | CEO, CFO, Director | G Gift | 2026-08-19 | 2026-08-21 | 88,400 | — | $0 | 129,288 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-09 | 2026-07-10 | 25,000 | $1.96 | $49.0K | 461,904 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-08 | 2026-07-10 | 20,000 | $1.99 | $39.8K | 436,904 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise deriv | 2026-07-07 | 2026-07-08 | 133 | — | $0 | 0 | SEC↗ |
| Finley John David | CEO, CFO | S Sale | 2026-07-07 | 2026-07-08 | 146,798 | $2.07 | $303.9K | 217,555 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise | 2026-07-07 | 2026-07-08 | 133 | $0.70 | $93 | 217,688 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | S Sale | 2026-07-07 | 2026-07-08 | 51,880 | $2.05 | $106.4K | 94,009 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-07 | 2026-07-08 | 30,000 | $2.03 | $60.9K | 416,904 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise deriv | 2026-07-06 | 2026-07-08 | 335,167 | — | $0 | 1,675,833 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2026-07-06 | 2026-07-08 | 131,167 | — | $0 | 655,833 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise | 2026-07-06 | 2026-07-08 | 335,167 | — | $0 | 364,353 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2026-07-06 | 2026-07-08 | 131,167 | — | $0 | 145,889 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-06 | 2026-07-08 | 20,000 | $2.05 | $41.0K | 386,904 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-02 | 2026-07-06 | 10,000 | $1.98 | $19.8K | 366,904 | SEC↗ |
| Baltera Robert Jr. | Director | P Buy | 2026-07-01 | 2026-07-06 | 20,000 | $1.98 | $39.6K | 356,904 | SEC↗ |
| Chuang Emil | Director | M Exercise deriv | 2026-06-10 | 2026-06-12 | 20,200 | — | $0 | 40,400 | SEC↗ |
| Williams Donald Allen | Director | M Exercise deriv | 2026-06-10 | 2026-06-12 | 60,666 | — | $0 | 121,334 | SEC↗ |
| Wei Binxian | Director | M Exercise deriv | 2026-06-10 | 2026-06-12 | 20,200 | — | $0 | 40,400 | SEC↗ |
| Zwick Jordan Michael | Director | A Award | 2026-06-10 | 2026-06-12 | 336,904 | — | $0 | 336,904 | SEC↗ |
| Chuang Emil | Director | M Exercise | 2026-06-10 | 2026-06-12 | 20,200 | — | $0 | 612,500 | SEC↗ |
| Chuang Emil | Director | A Award | 2026-06-10 | 2026-06-12 | 592,300 | — | $0 | 592,300 | SEC↗ |
| Williams Donald Allen | Director | A Award | 2026-06-10 | 2026-06-12 | 1,498,900 | — | $0 | 1,509,628 | SEC↗ |
| Williams Donald Allen | Director | M Exercise | 2026-06-10 | 2026-06-12 | 60,666 | — | $0 | 1,570,294 | SEC↗ |
| Wei Binxian | Director | M Exercise | 2026-06-10 | 2026-06-12 | 20,200 | — | $0 | 613,355 | SEC↗ |
| Wei Binxian | Director | A Award | 2026-06-10 | 2026-06-12 | 592,300 | — | $0 | 593,155 | SEC↗ |
| Baltera Robert Jr. | Director | A Award | 2026-06-10 | 2026-06-18 | 336,904 | — | $0 | 336,904 | SEC↗ |
| Finley John David | CEO, CFO | S Sale | 2026-02-12 | 2026-02-13 | 3,896 | $1.75 | $6.8K | 27,353 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | S Sale | 2026-02-12 | 2026-02-13 | 1,989 | $1.75 | $3.5K | 13,263 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 13,333 | — | $0 | 26,667 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2026-02-11 | 2026-02-13 | 8,000 | — | $0 | 16,000 | SEC↗ |
| Finley John David | CEO, CFO | M Exercise | 2026-02-11 | 2026-02-13 | 13,333 | — | $0 | 31,249 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2026-02-11 | 2026-02-13 | 8,000 | — | $0 | 15,252 | SEC↗ |
| Finley John David | CEO, CFO | A Award deriv | 2026-02-09 | 2026-02-11 | 2,011,000 | — | $0 | 2,011,000 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 787,000 | — | $0 | 787,000 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2026-01-16 | 2026-01-21 | 5,000 | $1.67 | $8.3K | 10,728 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2026-01-09 | 2026-01-13 | 5,000 | $1.88 | $9.4K | 5,728 | SEC↗ |
| Chuang Emil | Director | A Award deriv | 2025-10-06 | 2025-10-08 | 510,700 | — | $0 | 510,700 | SEC↗ |
| Finley John David | CEO, CFO | A Award deriv | 2025-10-06 | 2025-10-08 | 9,179,400 | — | $0 | 9,179,400 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2025-10-06 | 2025-10-08 | 7,665,800 | — | $0 | 7,665,800 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2025-10-06 | 2025-10-08 | 510,700 | — | $0 | 510,700 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2025-10-06 | 2025-10-08 | 1,538,700 | — | $0 | 1,538,700 | SEC↗ |
| Chuang Emil | Director | A Award deriv | 2025-10-06 | 2025-11-06 | 60,600 | — | $0 | 60,600 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2025-10-06 | 2025-11-06 | 60,600 | — | $0 | 60,600 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2025-10-06 | 2025-11-06 | 182,000 | — | $0 | 182,000 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2025-09-04 | 2025-09-05 | 18,800 | — | $0 | 18,800 | SEC↗ |
| Chuang Emil | Director | A Award deriv | 2025-09-04 | 2025-09-05 | 18,800 | — | $0 | 18,800 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2025-09-04 | 2025-09-05 | 64,400 | — | $0 | 64,400 | SEC↗ |
| Finley John David | CEO, CFO | A Award deriv | 2025-09-04 | 2025-09-05 | 323,400 | — | $0 | 323,400 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2025-09-04 | 2025-09-05 | 289,000 | — | $0 | 289,000 | SEC↗ |
| Chuang Emil | Director | A Award deriv | 2025-07-18 | 2025-07-22 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Finley John David | CEO, CFO | A Award deriv | 2025-02-11 | 2025-02-13 | 47,000 | — | $0 | 47,000 | SEC↗ |
| Finley John David | CEO, CFO | A Award deriv | 2025-02-11 | 2025-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2025-02-11 | 2025-02-13 | 29,000 | — | $0 | 29,000 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2025-02-11 | 2025-02-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Williams Donald Allen | Director | M Exercise | 2024-11-21 | 2024-11-22 | 388 | — | $0 | 728 | SEC↗ |
| Wei Binxian | Director | M Exercise | 2024-11-21 | 2024-11-22 | 388 | — | $0 | 855 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 2,100 | — | $0 | 2,100 | SEC↗ |
| Fischbein Margery B. | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 2,100 | — | $0 | 2,100 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 2,100 | — | $0 | 2,100 | SEC↗ |
| Williams Donald Allen | Director | M Exercise | 2024-06-11 | 2024-06-12 | 340 | — | $0 | 340 | SEC↗ |
| Wei Binxian | Director | M Exercise | 2024-06-11 | 2024-06-12 | 465 | — | $0 | 467 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-05-28 | 2024-05-30 | 1,622 | — | $0 | 0 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-05-28 | 2024-05-30 | 3,335 | — | $0 | 0 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-05-28 | 2024-05-30 | 2,111 | — | $0 | 0 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2024-05-28 | 2024-05-30 | 1,555 | — | $0 | 0 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2024-05-28 | 2024-05-30 | 2,735 | — | $0 | 0 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2024-05-28 | 2024-05-29 | 1,000 | $4.86 | $4.9K | 1,000 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-05-28 | 2024-05-30 | 2,111 | — | $0 | 14,079 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-05-28 | 2024-05-30 | 1,622 | — | $0 | 10,059 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2024-05-28 | 2024-05-30 | 467 | $4.76 | $2.2K | 9,592 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-05-28 | 2024-05-30 | 3,335 | — | $0 | 12,927 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2024-05-28 | 2024-05-30 | 959 | $4.76 | $4.6K | 11,968 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2024-05-28 | 2024-05-30 | 607 | $4.76 | $2.9K | 13,472 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | F Tax w/h | 2024-05-28 | 2024-05-30 | 461 | $4.76 | $2.2K | 3,852 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2024-05-28 | 2024-05-30 | 2,735 | — | $0 | 3,568 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | F Tax w/h | 2024-05-28 | 2024-05-30 | 810 | $4.76 | $3.9K | 2,758 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2024-05-28 | 2024-05-30 | 1,555 | — | $0 | 4,313 | SEC↗ |
| Finley John David | CEO, CFO, Director | P Buy | 2024-05-24 | 2024-05-28 | 1,000 | $4.81 | $4.8K | 8,437 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award | 2024-05-20 | 2024-05-22 | 666 | $4.97 | $3.3K | 7,437 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-05-06 | 2024-05-08 | 211 | — | $0 | 2,111 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-05-06 | 2024-05-08 | 232 | — | $0 | 1,622 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | M Exercise deriv | 2024-05-06 | 2024-05-08 | 304 | — | $0 | 2,735 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | M Exercise deriv | 2024-05-06 | 2024-05-08 | 156 | — | $0 | 1,555 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2024-05-06 | 2024-05-08 | 67 | $8.46 | $567 | 6,621 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-05-06 | 2024-05-08 | 211 | — | $0 | 6,832 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2024-05-06 | 2024-05-08 | 61 | $8.46 | $516 | 6,771 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-05-06 | 2024-05-08 | 232 | — | $0 | 6,688 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | F Tax w/h | 2024-05-06 | 2024-05-08 | 90 | $8.46 | $761 | 724 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | M Exercise | 2024-05-06 | 2024-05-08 | 156 | — | $0 | 880 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | F Tax w/h | 2024-05-06 | 2024-05-08 | 47 | $8.46 | $398 | 833 | SEC↗ |
| Jones Mitchell Lawrence | CEO, CFO, Director | M Exercise | 2024-05-06 | 2024-05-08 | 304 | — | $0 | 814 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-03-11 | 2024-03-12 | 5,558 | — | $0 | 50,025 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-03-11 | 2024-03-12 | 5,558 | — | $0 | 96,849 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 6,880 | — | $0 | 0 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 12,160 | — | $0 | 0 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 5,820 | — | $0 | 0 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 5,100 | — | $0 | 0 | SEC↗ |
| Neal James R | Director | M Exercise deriv | 2024-02-09 | 2024-02-13 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Neal James R | Director | M Exercise | 2024-02-09 | 2024-02-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| Neal James R | Director | M Exercise | 2024-02-09 | 2024-02-13 | 5,820 | — | $0 | 10,920 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 9,580 | — | $0 | 9,580 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,980 | — | $0 | 0 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 0 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 9,580 | — | $0 | 9,580 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 9,580 | — | $0 | 0 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 0 | SEC↗ |
| Csimma Cristina | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,980 | — | $0 | 0 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 0 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 9,580 | — | $0 | 0 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 0 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 12,160 | — | $0 | 0 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 0 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 5,100 | — | $0 | 0 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Diaz Stephanie | Director | M Exercise deriv | 2024-02-08 | 2024-02-13 | 6,880 | — | $0 | 0 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 10,920 | SEC↗ |
| Trenschel Robert J. | Director | M Exercise | 2024-02-08 | 2024-02-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| Diaz Stephanie | Director | M Exercise | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 12,800 | SEC↗ |
| Diaz Stephanie | Director | M Exercise | 2024-02-08 | 2024-02-13 | 6,980 | — | $0 | 6,980 | SEC↗ |
| Csimma Cristina | Director | M Exercise | 2024-02-08 | 2024-02-13 | 6,980 | — | $0 | 7,042 | SEC↗ |
| Csimma Cristina | Director | M Exercise | 2024-02-08 | 2024-02-13 | 5,820 | — | $0 | 12,862 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-02-06 | 2024-02-08 | 3,167 | — | $0 | 34,833 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-02-06 | 2024-02-08 | 3,475 | — | $0 | 27,800 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2024-02-06 | 2024-02-08 | 4,558 | — | $0 | 45,586 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2024-02-06 | 2024-02-08 | 2,333 | — | $0 | 25,667 | SEC↗ |
| Finley John David | CEO, CFO, Director | P Buy | 2024-02-06 | 2024-02-07 | 10,000 | $0.47 | $4.7K | 84,649 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-02-06 | 2024-02-08 | 3,475 | — | $0 | 88,124 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-02-06 | 2024-02-08 | 3,167 | — | $0 | 91,291 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2024-02-06 | 2024-02-08 | 2,333 | — | $0 | 9,815 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | F Tax w/h | 2024-02-06 | 2024-02-08 | 2,153 | $0.44 | $947 | 7,662 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2024-02-06 | 2024-02-08 | 4,558 | — | $0 | 7,482 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2024-01-31 | 2024-02-01 | 10,000 | $0.61 | $6.1K | 30,000 | SEC↗ |
| Finley John David | CEO, CFO, Director | P Buy | 2024-01-31 | 2024-02-01 | 10,000 | $0.56 | $5.6K | 74,649 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2024-01-03 | 2024-01-05 | 1,309 | — | $0 | 0 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2024-01-03 | 2024-01-05 | 1,309 | — | $0 | 64,649 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-12-11 | 2023-12-19 | 5,559 | — | $0 | 55,583 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-12-11 | 2023-12-19 | 5,559 | — | $0 | 63,340 | SEC↗ |
| Trenschel Robert J. | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-11-21 | 2023-11-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-11-21 | 2023-11-24 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2023-11-21 | 2023-11-24 | 33,160 | — | $0 | 33,160 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | A Award deriv | 2023-11-21 | 2023-11-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Neal James R | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Neal James R | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 5,820 | — | $0 | 5,820 | SEC↗ |
| Trenschel Robert J. | Director | A Award deriv | 2023-11-21 | 2023-11-24 | 6,880 | — | $0 | 6,880 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award | 2023-11-20 | 2023-11-24 | 10,000 | $0.51 | $5.1K | 57,781 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | F Tax w/h | 2023-11-07 | 2023-11-08 | 1,630 | $0.54 | $880 | 2,926 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise deriv | 2023-11-06 | 2023-11-08 | 4,556 | — | $0 | 50,144 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-11-06 | 2023-11-08 | 3,475 | — | $0 | 31,275 | SEC↗ |
| Jones Mitchell Lawrence | Chief Medical Officer | M Exercise | 2023-11-06 | 2023-11-08 | 4,556 | — | $0 | 4,556 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-11-06 | 2023-11-08 | 3,475 | — | $0 | 47,781 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-10-04 | 2023-10-05 | 397 | $0.55 | $218 | 44,306 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-10-03 | 2023-10-05 | 1,309 | — | $0 | 1,309 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-10-03 | 2023-10-05 | 1,309 | — | $0 | 44,703 | SEC↗ |
| Finley John David | CEO, CFO, Director | P Buy | 2023-09-27 | 2023-09-29 | 15,000 | $0.54 | $8.1K | 43,394 | SEC↗ |
| Williams Donald Allen | Director | P Buy | 2023-09-27 | 2023-09-29 | 20,000 | $0.54 | $10.8K | 20,000 | SEC↗ |
| Trenschel Robert J. | Director | S Sale | 2023-09-14 | 2023-09-15 | 300 | $0.64 | $192 | 0 | SEC↗ |
| Finley John David | CEO, CFO, Director | P Buy | 2023-09-13 | 2023-09-14 | 15,000 | $0.66 | $9.9K | 28,394 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-09-12 | 2023-09-13 | 1,792 | $0.66 | $1.2K | 13,394 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-09-11 | 2023-09-13 | 5,558 | — | $0 | 61,142 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-09-11 | 2023-09-13 | 5,558 | — | $0 | 15,186 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-08-11 | 2023-08-14 | 1,040 | $0.70 | $728 | 9,628 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-08-06 | 2023-08-14 | 3,475 | — | $0 | 34,750 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-08-06 | 2023-08-14 | 3,475 | — | $0 | 11,057 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-07-06 | 2023-07-06 | 389 | $1.76 | $685 | 7,193 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-07-03 | 2023-07-06 | 1,309 | — | $0 | 2,618 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-07-03 | 2023-07-06 | 1,309 | — | $0 | 7,582 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-06-13 | 2023-06-14 | 1,050 | $1.54 | $1.6K | 6,273 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-06-12 | 2023-06-14 | 3,475 | — | $0 | 38,225 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-06-12 | 2023-06-14 | 3,475 | — | $0 | 7,323 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 6,980 | — | $0 | 6,980 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 9,580 | — | $0 | 9,580 | SEC↗ |
| Trenschel Robert J. | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| Trenschel Robert J. | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 9,580 | — | $0 | 9,580 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 9,580 | — | $0 | 9,580 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 6,980 | — | $0 | 6,980 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 6,980 | — | $0 | 6,980 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-06-11 | 2023-06-13 | 66,700 | — | $0 | 66,700 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-06-11 | 2023-06-13 | 148,500 | — | $0 | 148,500 | SEC↗ |
| Neal James R | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 5,100 | — | $0 | 5,100 | SEC↗ |
| Neal James R | Director | A Award deriv | 2023-06-11 | 2023-06-13 | 12,160 | — | $0 | 12,160 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise deriv | 2023-04-03 | 2023-04-05 | 1,309 | — | $0 | 3,927 | SEC↗ |
| McRae Robert Curtis | Chief Operating Officer | M Exercise deriv | 2023-04-03 | 2023-04-05 | 655 | — | $0 | 1,963 | SEC↗ |
| Finley John David | CEO, CFO, Director | F Tax w/h | 2023-04-03 | 2023-04-05 | 435 | $2.01 | $874 | 3,848 | SEC↗ |
| Finley John David | CEO, CFO, Director | M Exercise | 2023-04-03 | 2023-04-05 | 1,309 | — | $0 | 4,283 | SEC↗ |
| McRae Robert Curtis | Chief Operating Officer | M Exercise | 2023-04-03 | 2023-04-05 | 655 | — | $0 | 895 | SEC↗ |
| McRae Robert Curtis | Chief Operating Officer | F Tax w/h | 2023-04-03 | 2023-04-05 | 270 | $2.00 | $540 | 625 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-02-06 | 2023-02-08 | 41,700 | — | $0 | 41,700 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-02-06 | 2023-02-08 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Finley John David | CEO, CFO, Director | A Award deriv | 2023-02-06 | 2023-02-08 | 57,200 | — | $0 | 57,200 | SEC↗ |
| Finley John David | Chief Executive Officer | A Award deriv | 2023-01-03 | 2023-01-06 | 5,236 | — | $0 | 5,236 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2022-09-01 | 2022-09-02 | 19,481 | $0.14 | $2.7K | 148,727 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2022-08-23 | 2022-08-25 | 7,350 | $0.16 | $1.2K | 129,246 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy deriv | 2022-08-16 | 2022-08-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy deriv | 2022-08-16 | 2022-08-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | P Buy deriv | 2022-08-16 | 2022-08-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | P Buy deriv | 2022-08-16 | 2022-08-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2022-08-16 | 2022-08-18 | 100,000 | $0.25 | $25.0K | 121,896 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | P Buy | 2022-08-16 | 2022-08-18 | 40,000 | $0.25 | $10.0K | 57,592 | SEC↗ |
| Finley John David | Chief Financial Officer | J Other | 2022-04-29 | 2022-05-02 | 12,545 | — | $0 | 38,867 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | P Buy | 2022-03-29 | 2022-03-31 | 15,000 | $1.14 | $17.1K | 15,000 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | P Buy | 2022-03-28 | 2022-03-29 | 10,000 | $1.18 | $11.8K | 17,592 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2022-03-24 | 2022-03-25 | 7,500 | $1.09 | $8.2K | 21,896 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 32,400 | — | $0 | 32,400 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 64,800 | — | $0 | 64,800 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2022-02-17 | 2022-02-22 | 156,600 | — | $0 | 156,600 | SEC↗ |
| GRAY MARY ANN | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Wei Binxian | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Neal James R | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Williams Donald Allen | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Trenschel Robert J. | Director | A Award deriv | 2021-11-18 | 2022-02-10 | 48,340 | — | $0 | 48,340 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-11-18 | 2022-02-10 | 267,868 | — | $0 | 267,868 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-11-18 | 2022-02-10 | 178,091 | — | $0 | 178,091 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-11-18 | 2022-02-10 | 39,294 | — | $0 | 39,294 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | P Buy | 2021-09-21 | 2021-09-22 | 6,000 | $2.49 | $14.9K | 7,592 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2021-09-21 | 2021-09-22 | 2,000 | $2.44 | $4.9K | 14,396 | SEC↗ |
| Trenschel Robert J. | Director | P Buy | 2021-09-10 | 2021-09-13 | 2,142 | $2.98 | $6.4K | 14,999 | SEC↗ |
| Trenschel Robert J. | Director | P Buy | 2021-09-09 | 2021-09-13 | 3,400 | $2.89 | $9.8K | 12,857 | SEC↗ |
| Trenschel Robert J. | Director | P Buy | 2021-09-08 | 2021-09-13 | 5,000 | $2.75 | $13.8K | 9,457 | SEC↗ |
| Trenschel Robert J. | Director | P Buy | 2021-09-07 | 2021-09-13 | 2,707 | $2.78 | $7.5K | 4,457 | SEC↗ |
| Trenschel Robert J. | Director | P Buy | 2021-08-31 | 2021-09-13 | 1,750 | $2.75 | $4.8K | 1,750 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2021-08-27 | 2021-08-30 | 1,600 | $2.63 | $4.2K | 3,996 | SEC↗ |
| Finley John David | Chief Financial Officer | P Buy | 2021-08-27 | 2021-08-30 | 8,400 | $2.65 | $22.3K | 12,396 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 1,962 | — | $0 | 1,962 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 5,084 | — | $0 | 5,084 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 2,800 | — | $0 | 2,800 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 5,438 | — | $0 | 5,438 | SEC↗ |
| Dawson Michael John | Chief Medical Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 20,391 | — | $0 | 20,391 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 10,203 | — | $0 | 10,203 | SEC↗ |
| Diaz Stephanie | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 4,406 | — | $0 | 4,406 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 49 | — | $0 | 49 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 2,595 | — | $0 | 2,595 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 7,952 | — | $0 | 7,952 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 9,702 | — | $0 | 9,702 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 19,033 | — | $0 | 19,033 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 5,662 | — | $0 | 5,662 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 14,708 | — | $0 | 14,708 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 52,068 | — | $0 | 52,068 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 9,516 | — | $0 | 9,516 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 10,418 | — | $0 | 10,418 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 293 | — | $0 | 293 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 325 | — | $0 | 325 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 27 | — | $0 | 27 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 516 | — | $0 | 516 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 40 | — | $0 | 40 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 503 | — | $0 | 503 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 339 | — | $0 | 339 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 95 | — | $0 | 95 | SEC↗ |
| Finley John David | Chief Financial Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 51 | — | $0 | 51 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 12,294 | — | $0 | 12,294 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 15,002 | — | $0 | 15,002 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 20,392 | — | $0 | 20,392 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 8,754 | — | $0 | 8,754 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 22,730 | — | $0 | 22,730 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 27,190 | — | $0 | 27,190 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 2,719 | — | $0 | 2,719 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 477 | — | $0 | 477 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 6,797 | — | $0 | 6,797 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 27,189 | — | $0 | 27,189 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 4,078 | — | $0 | 4,078 | SEC↗ |
| Hallam Thomas | Chief Executive Officer | A Award deriv | 2021-04-27 | 2021-04-29 | 95,572 | — | $0 | 95,572 | SEC↗ |
| Neal James R | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 4,406 | — | $0 | 4,406 | SEC↗ |
| Neal James R | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 5,091 | — | $0 | 5,091 | SEC↗ |
| Neal James R | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 3,398 | — | $0 | 3,398 | SEC↗ |
| Neal James R | Director | A Award deriv | 2021-04-27 | 2021-04-29 | 849 | — | $0 | 849 | SEC↗ |